Andreas E. Albers

Professor

Medical School Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

About

Andreas E. Albers is a Professor at the Medical School Berlin, Germany. His research focuses on head and neck cancer, particularly related to human papillomavirus, and includes topics such as molecular profiling, advanced nanomedicine, and oncolytic virotherapy. Recent publications reflect his work on the integration of viral oncogenes in cancer progression and the impact of smoking on survival rates in HPV-positive patients.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Andreas M. Kaufmann

GERMANY

View details

Konrad Klinghammer

charité university hospital

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas E. Albers

Research Interests

Explore related searches

About

Articles (11)

Identifying Truly HPV-Driven Head and Neck Squamous Cell Carcinoma by QuantiGene-Molecular-Profiling-Histology Assay Allows for More Precise Prognosis Prediction

Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.

Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysis.

Impact of smoking on the survival of patients with high-risk HPV-positive HNSCC: A meta-analysis

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Immunotherapeutics for head and neck squamous cell carcinoma stem cells.

Collaborators (2)

Andreas M. Kaufmann

Konrad Klinghammer

Make your next move.